Literature DB >> 19332848

Hepatocellular carcinoma in patients with cirrhosis: qualitative comparison of gadobenate dimeglumine-enhanced MR imaging and multiphasic 64-section CT.

Daniele Marin1, Michele Di Martino, Antonino Guerrisi, Gianmaria De Filippis, Massimo Rossi, Stefano Ginanni Corradini, Raffaele Masciangelo, Carlo Catalano, Roberto Passariello.   

Abstract

PURPOSE: To prospectively investigate whether combined interpretation of dynamic and hepatobiliary phase magnetic resonance (MR) images can improve the accuracy of gadobenate dimeglumine-enhanced MR imaging in the detection of hepatocellular carcinoma (HCC) compared with either dynamic MR or multiphasic multidetector computed tomographic (CT) images alone.
MATERIALS AND METHODS: Institutional review board approval and informed patient consent were obtained. Fifty-two patients (39 men, 13 women; mean age, 68 years; range, 38-81 years) suspected of having HCC underwent gadobenate dimeglumine-enhanced MR imaging and multiphasic 64-section multidetector CT. Images were qualitatively analyzed independently by three observers in three separate reading sessions. The alternating free-response receiver operating characteristic (AFROC) method was used to analyze the results. Differences in sensitivity and positive predictive values were calculated at a statistical significance of P < .05.
RESULTS: A total of 67 HCCs were detected in 36 patients. The mean area under the AFROC curve (A(z)) was significantly higher for either the combined interpretation of dynamic and hepatobiliary phase MR images (A(z) = 0.95) or dynamic MR images alone (0.91) than for CT images (0.77) (P = .01 for both comparisons). The mean sensitivity of combined interpretation of MR images (0.72) was significantly higher than those of dynamic MR images alone (0.63) and multidetector CT images (0.61) (P = .008 and .001, respectively). The mean positive predictive value was not significantly different among the three imaging sets.
CONCLUSION: The combined interpretation of dynamic and hepatobiliary phase MR images improves diagnostic accuracy of gadobenate dimeglumine-enhanced MR imaging for the detection of HCC compared with either dynamic MR or multiphasic multidetector CT images alone.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19332848     DOI: 10.1148/radiol.2511080400

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  26 in total

1.  Evaluation of a method for improving the detection of hepatocellular carcinoma.

Authors:  Edgar Bendik; Peter B Noël; Daniela Münzel; Alexander A Fingerle; Martin Henninger; Christian Markus; Alain Vlassenbroek; Ernst J Rummeny; Martin Dobritz
Journal:  Eur Radiol       Date:  2013-09-03       Impact factor: 5.315

2.  Optimized high-resolution contrast-enhanced hepatobiliary imaging at 3 tesla: a cross-over comparison of gadobenate dimeglumine and gadoxetic acid.

Authors:  Alex Frydrychowicz; Scott K Nagle; Sharon L D'Souza; Karl K Vigen; Scott B Reeder
Journal:  J Magn Reson Imaging       Date:  2011-07-12       Impact factor: 4.813

3.  Contribution of the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI to Dynamic MRI in the detection of hypovascular small (≤ 2 cm) HCC in cirrhosis.

Authors:  Rita Golfieri; Matteo Renzulli; Vincenzo Lucidi; Beniamino Corcioni; Franco Trevisani; Luigi Bolondi
Journal:  Eur Radiol       Date:  2011-02-05       Impact factor: 5.315

4.  Effectiveness of temporal and dynamic subtraction images of the liver for detection of small HCC on abdominal CT images: comparison of 3D nonlinear image-warping and 3D global-matching techniques.

Authors:  Eiichiro Okumura; Shigeru Sanada; Masayuki Suzuki; Akihiro Takemura; Osamu Matsui
Journal:  Radiol Phys Technol       Date:  2011-01-13

Review 5.  Magnetic resonance imaging of the cirrhotic liver in the era of gadoxetic acid.

Authors:  Francesco Agnello; Marco Dioguardi Burgio; Dario Picone; Federica Vernuccio; Giuseppe Cabibbo; Lydia Giannitrapani; Adele Taibbi; Antonino Agrusa; Tommaso Vincenzo Bartolotta; Massimo Galia; Roberto Lagalla; Massimo Midiri; Giuseppe Brancatelli
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 6.  Advances in computed tomography and magnetic resonance imaging of hepatocellular carcinoma.

Authors:  Tiffany Hennedige; Sudhakar K Venkatesh
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

7.  Hypervascular hepatocellular carcinomas: detection with gadoxetate disodium-enhanced MR imaging and multiphasic multidetector CT.

Authors:  Hiromitsu Onishi; Tonsok Kim; Yasuharu Imai; Masatoshi Hori; Hiroaki Nagano; Yasuhiro Nakaya; Takahiro Tsuboyama; Atsushi Nakamoto; Mitsuaki Tatsumi; Seishi Kumano; Masahiro Okada; Manabu Takamura; Kenichi Wakasa; Noriyuki Tomiyama; Takamichi Murakami
Journal:  Eur Radiol       Date:  2011-11-07       Impact factor: 5.315

Review 8.  New paradigm for management of hepatocellular carcinoma by imaging.

Authors:  Ijin Joo; Byung Ihn Choi
Journal:  Liver Cancer       Date:  2012-09       Impact factor: 11.740

Review 9.  Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma.

Authors:  Simona Bota; Fabio Piscaglia; Sara Marinelli; Anna Pecorelli; Eleonora Terzi; Luigi Bolondi
Journal:  Liver Cancer       Date:  2012-11       Impact factor: 11.740

Review 10.  Multiparametric MR Imaging in Abdominal Malignancies.

Authors:  Antonio Luna; Shivani Pahwa; Claudio Bonini; Lidia Alcalá-Mata; Katherine L Wright; Vikas Gulani
Journal:  Magn Reson Imaging Clin N Am       Date:  2016-02       Impact factor: 2.266

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.